-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Management and key personnel in Medistim ASA purchases shares
20 Jun 2025 10:41 CEST
Issuer
Medistim ASA
Management and key personnel in Medistim ASA have the 20th of June purchased
shares form Medistim ASA. This is part of the company long term incentive plan
approved by the general meeting the 8th of May 2025. Price per share was NOK
161,60. The following members of management and key personnel have purchased
shares:
VP marketing Hæge Wetterhus purchased 619 shares and has 2210 shares after the
purchase.
Chief Business Development Officer Ole Arne Eiksund purchased 1856 shares and
has 7728 shares after the purchase.
VP Innovation Håkon Grøthe purchased 1856 shares and has 9677shares after the
purchase.
Team leader SW Jonas Crosby purchased 928 shares and has 928 shares after the
purchase.
Team leader HW Anders Wangensten purchased 1856 shares and has 1856 shares after
the purchase.
Tech lead Robert Hurry purchased 1856 shares and has 1856 shares after the
purchase.
Business and product manager for Cardiac Tore Skjeggestad purchased 1856 shares
and has 1856 shares after the purchase.
Business and product manager for Vascular Andre Hagen purchased 1856 shares and
has 1856 shares after the purchase.
Medical advisor Kjersti Johansen purchased 1856 shares and has 1856 shares after
the purchase.
Finance manager Espen Bjørsnøs purchased 1856 shares and has 1856 shares after
the purchase.
CFO Thomas Jakobsen purchased 2475 shares and has 33001 shares after the
purchase.
Medistim ASA sold 18874 shares and has 74243 own shares after the sale.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Medistim ASA
Provider
Oslo Børs Newspoint
Company Name
MEDISTIM
ISIN
NO0010159684
Symbol
MEDI
Market
Euronext Oslo Børs